Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1
Open Access
- 28 January 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 131 (4), 539-548
- https://doi.org/10.1007/s00401-016-1538-0
Abstract
Accruing evidence suggests that prion-like behavior of fibrillar forms of α-synuclein, β-amyloid peptide and mutant huntingtin are responsible for the spread of the lesions that characterize Parkinson disease, Alzheimer disease and Huntington disease, respectively. It is unknown whether these distinct protein assemblies are transported within and between neurons by similar or distinct mechanisms. It is also unclear if neuronal death or injury is required for neuron-to-neuron transfer. To address these questions, we used mouse primary cortical neurons grown in microfluidic devices to measure the amounts of α-synuclein, Aβ42 and HTTExon1 fibrils transported by axons in both directions (anterograde and retrograde), as well as to examine the mechanism of their release from axons after anterograde transport. We observed that the three fibrils were transported in both anterograde and retrograde directions but with strikingly different efficiencies. The amount of Aβ42 fibrils transported was ten times higher than that of the other two fibrils. HTTExon1 was efficiently transported in the retrograde direction but only marginally in the anterograde direction. Finally, using neurons from two distinct mutant mouse strains whose axons are highly resistant to neurodegeneration (WldS and Sarm1−/−), we found that the three different fibrils were secreted by axons after anterograde transport, in the absence of axonal lysis, indicating that trans-neuronal spread can occur in intact healthy neurons. In summary, fibrils of α-synuclein, Aβ42 and HTTExon1 are all transported in axons but in directions and amounts that are specific of each fibril. After anterograde transport, the three fibrils were secreted in the medium in the absence of axon lysis. Continuous secretion could play an important role in the spread of pathology between neurons but may be amenable to pharmacological intervention.Keywords
Funding Information
- Novartis Institutes of Biomedical Research
- Agence Nationale de la Recherche (JPND-NeuTARGETs-ANR-14-JPCD-0002-02)
- Centre National de la Recherche Scientifique
- Fondation Bettencourt Schueller
- National Institutes of Health (1DP1OD019046)
This publication has 55 references indexed in Scilit:
- α-Synuclein strains cause distinct synucleinopathies after local and systemic administrationNature, 2015
- Propagation of Tau Pathology in a Model of Early Alzheimer's DiseaseNeuron, 2012
- Glutamate and Amyloid β-Protein Rapidly Inhibit Fast Axonal Transport in Cultured Rat Hippocampal Neurons by Different MechanismsJournal of Neuroscience, 2003
- Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogenJournal of Neural Transmission, 2003
- Intraneuronal Alzheimer Aβ42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic PathologyThe American Journal of Pathology, 2002
- Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)Zeitschrift für Neurologie, 2002
- Phases of Aβ-deposition in the human brain and its relevance for the development of ADNeurology, 2002
- A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Tracing of neuronal connections with cholera toxin subunit B: light and electron microscopic immunohistochemistry using monoclonal antibodiesJournal of Neuroscience Methods, 1988
- Some Speculations about Prions, Amyloid, and Alzheimer's DiseaseThe New England Journal of Medicine, 1984